Home
Browse All Titles
Sign In
Browse All Titles
Physicians' Cancer Chemotherapy Drug Manual
About
Table of Contents
Main Index
Trade Names
Classification Index
Category Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002
Physicians' Cancer Chemotherapy Drug Manual
GoogleAnalytics
Purchase entire reference Mobile/Web for $69.99
PURCHASE NOW
Already Purchased?
Sign In
Table of Contents
Free Topics
5-Fluorouracil
About
Bladder Cancer
Breast Cancer
Cervical Cancer
Cladribine
Decitabine
Epirubicin
Floxuridine
Fludarabine
Idarubicin
Preface
1. Principles of Cancer Chemotherapy
1. Principles of Cancer Chemotherapy
Principles of Combination Chemotherapy
The Role of Chemotherapy in the Treatment of Cancer
2. Chemotherapeutic and Biologic Drugs
2. Chemotherapeutic and Biologic Drugs
5-Fluorouracil
Abemaciclib
Abiraterone Acetate
Acalabrutinib
Adagrasib
Ado-trastuzumab emtansine
Afatinib
Albumin-Bound Paclitaxel
Aldesleukin
Alectinib
Alemtuzumab
Alpelisib
Altretamine
Aminoglutethimide
Amivantamab-vmjw
Anastrozole
Apalutamide
Arsenic trioxide (As2O3)
Asciminib
Asparaginase ewinia chrysantemi-rywn
Atezolizumab
Avapritinib
Avelumab
Axicabtagene ciloleucel
Axitinib
Azacitidine
Belantamab mafodotin-blmf
Belinostat
Bendamustine
Bevacizumab
Bexarotene
Bezultifan
Bicalutamide
Binimetinib
Bleomycin
Blinatumomab
Bortezomib
Bosutinib
Brentuximab
Brexucabtagene autoleucel
Brigatinib
Busulfan
Cabazitaxel
Cabozantinib
Calaspargase pegol-mknl
Capecitabine
Capmatinib
Carboplatin
Carfilzomib
Carmustine
Cemiplimab-rwlc
Ceritinib
Cetuximab
Chlorambucil
Cisplatin
Cladribine
Clofarabine
Cobimetinib
Copanlisib
Crizotinib
Cyclophosphamide
Cytarabine
Dabrafenib
Dacarbazine
Dacomitinib
Dactinomycin-D
Daratumumab
Daratumumab and Hyaluronidase-fihj
Dasatinib
Daunorubicin
Daunorubicin and Cytarabine Liposome
Daunorubicin Liposome
Decitabine
Decitabine-Cedazuridine
Degarelix
Denileukin diftitox
Docetaxel
Dostarlimab-gxly
Doxorubicin
Doxorubicin liposome
Durvalumab
Duvelisib
Elacestrant
Elotuzumab
Enasidenib
Encorafenib
Enfortumab vedotin-ejfv
Entrectinib
Enzalutamide
Epcoritamab
Epirubicin
Erdafitinib
Eribulin
Erlotinib
Estramustine
Etoposide
Etoposide phosphate
Everolimus
Exemestane
Floxuridine
Fludarabine
Flutamide
Fulvestrant
Futibatinib
Gefitinib
Gemcitabine
Gemtuzumab ozogamicin
Gilteritinib
Glasdegib
Glofitamab
Goserelin
Hydroxyurea
Ibritumomab
Ibrutinib
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imatinib
Infigratinib
Inotuzumab ozogamicin
Interferon
Ipilimumab
Irinotecan
Irinotecan liposome
Isatuximab
Ivosidenib
Ixabepilone
Ixazomib
Lapatinib
Larotrectinib
Lenalidomide
Lenvatinib
Letrozole
Leuprolide
Lisocabtagene maraleucel
Lomustine
Loncastuximab tesirine-lpyl
Lorlatinib
Lurbinectedin
Lutetium Lu 177 dotatate
Margetuximab-cmkb
Mechlorethamine
Megestrol acetate
Melphalan
Melphalan flufenamide
Mercaptopurine
Methotrexate
Midostaurin
Mirvetuximab soravtansine-gynx
Mitomycin-C
Mitotane
Mitoxantrone
Mobocertinib
Mogamulizumab-kpkc
Mosunetuzumab
Moxetumomab pasudotox
Nadofaragene firadenovec-vcng
Necitumumab
Nelarabine
Neratinib
Nilotinib
Nilutamide
Niraparib
Niraparib and Abiraterone
Nivolumab
Obinutuzumab
Ofatumumab
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Osimertinib
Oxaliplatin
Paclitaxel
Palbociclib
Panitumumab
Panobinostat
Pazopanib
Pegaspargase
Pembrolizumab
Pemetrexed
Pemigatinib
Pertuzumab
Pirtobrutinib
Polatuzumab vedotin
Pomalidomide
Ponatinib
Pralatrexate
Pralsetinib
Procarbazine
Quazartinib
Ramucirumab
Regorafenib
Relatlimab
Relugolix
Retifanlimab
Ribociclib
Ripretinib
Rituximab
Rituximab and human hyaluronidase
Rituximab-abbs
Rituximab-pvvr
Romidepsin
Rucaparib
Sacituzumab govitecan
Selinexor
Selpercatinib
Sipuleucel-T
Sonidegib
Sorafenib
Sotorasib
Streptozocin
Sunitinib
Tafasitamab-cxix
Tagraxofusp-erzs
Talazoparib
Talimogene Laherparepvec
Talquetamab
Tamoxifen
TAS-102
Tazemetostat
Tebentafusp-tebn
Teclistamab-cqyv
Temozolomide
Temsirolimus
Tepotinib
Thalidomide
Thioguanine
Thiotepa
Tisagenlecleucel
Tisotumab vedotin-tftv
Tivozanib
Topotecan
Toremifene
Tositumomab
Trabectedin
Trametinib
Trastuzumab
Trastuzumab deruxtecan
Trastuzumab-pkrb
Tremelimumab-actl
Tretinoin
Tucatinib
Umbralisib
Vandetanib
Vemurafenib
Venetoclax
Vinblastine
Vincristine
Vinorelbine
Vismodegib
Vorinostat
Zanubrutinib
Ziv-aflibercept
3. Guidelines for Chemotherapy and Dosing Modifications
3. Guidelines for Chemotherapy and Dosing Modifications
Box 3-1. Determination of Creatinine Clearance
Box 3-2. Determination of Target Area Under the Curve (AUC)
Box 3-3. Determination of Drug Dose
Box 3-4. Classification of Teratogenic Potential and Use in Pregnancy for Chemotherapy Agents
Table 3-1. Performance Scales
Table 3-2. Calculation of Body Surface Area in Adult Amputees
Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
4. Common Chemotherapy Regimens in Clinical Practice
4. Common Chemotherapy Regimens in Clinical Practice
Adrenocortical Cancer
Anal Cancer
Basal Cell Cancer
Biliary Tract Cancer
Bladder Cancer
Blastic Dendritic Cell Plasmacytoid Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Carcinoid Tumors and Neuroendocrine Tumors
Cervical Cancer
Colorectal Cancer
Endometrial Cancer
Esophageal Cancer
Gastric Cancer
Gastrointestinal Stromal Tumor (GIST)
Head and Neck Cancer
Hepatocellular Cancer
Kaposi's Sarcoma
Leukemia
Lung Cancer
Lymphoma
Malignant Melanoma
Malignant Mesothelioma
Merkel Cell Cancer
Multiple Myeloma
Myelodysplastic Syndrome
NTRK Gene Fusion Cancer
Osteogenic Sarcoma
Ovarian Cancer (Epithelial)
Ovarian Cancer (Germ Cell)
Pancreatic Cancer
Prostate Cancer
References
Renal Cell Cancer
Soft Tissue Sarcomas
Squamous Cell Cancer of the Skin
Testicular Cancer
Thymoma
Thyroid Cancer
Von Hippel-Landau Associated Cancers
Waldenström's Macroglobulinemia
5. Antiemetic Agents for the Treatment of Chemotherapy-Induced Nausea and Vomiting
5. Antiemetic Agents for the Treatment of Chemotherapy-Induced Nausea and Vomiting
Common Regimens for Chemotherapy-Induced Nausea and Vomiting
Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting:
Common Regimens for Radiation-Induced Nausea and Vomiting:
Front Matter
Preface
Table of Contents
Free Topics
5-Fluorouracil
About
Bladder Cancer
Breast Cancer
Cervical Cancer
Cladribine
Decitabine
Epirubicin
Floxuridine
Fludarabine
Idarubicin
Preface
1. Principles of Cancer Chemotherapy
1. Principles of Cancer Chemotherapy
Principles of Combination Chemotherapy
The Role of Chemotherapy in the Treatment of Cancer
2. Chemotherapeutic and Biologic Drugs
2. Chemotherapeutic and Biologic Drugs
5-Fluorouracil
Abemaciclib
Abiraterone Acetate
Acalabrutinib
Adagrasib
Ado-trastuzumab emtansine
Afatinib
Albumin-Bound Paclitaxel
Aldesleukin
Alectinib
Alemtuzumab
Alpelisib
Altretamine
Aminoglutethimide
Amivantamab-vmjw
Anastrozole
Apalutamide
Arsenic trioxide (As2O3)
Asciminib
Asparaginase ewinia chrysantemi-rywn
Atezolizumab
Avapritinib
Avelumab
Axicabtagene ciloleucel
Axitinib
Azacitidine
Belantamab mafodotin-blmf
Belinostat
Bendamustine
Bevacizumab
Bexarotene
Bezultifan
Bicalutamide
Binimetinib
Bleomycin
Blinatumomab
Bortezomib
Bosutinib
Brentuximab
Brexucabtagene autoleucel
Brigatinib
Busulfan
Cabazitaxel
Cabozantinib
Calaspargase pegol-mknl
Capecitabine
Capmatinib
Carboplatin
Carfilzomib
Carmustine
Cemiplimab-rwlc
Ceritinib
Cetuximab
Chlorambucil
Cisplatin
Cladribine
Clofarabine
Cobimetinib
Copanlisib
Crizotinib
Cyclophosphamide
Cytarabine
Dabrafenib
Dacarbazine
Dacomitinib
Dactinomycin-D
Daratumumab
Daratumumab and Hyaluronidase-fihj
Dasatinib
Daunorubicin
Daunorubicin and Cytarabine Liposome
Daunorubicin Liposome
Decitabine
Decitabine-Cedazuridine
Degarelix
Denileukin diftitox
Docetaxel
Dostarlimab-gxly
Doxorubicin
Doxorubicin liposome
Durvalumab
Duvelisib
Elacestrant
Elotuzumab
Enasidenib
Encorafenib
Enfortumab vedotin-ejfv
Entrectinib
Enzalutamide
Epcoritamab
Epirubicin
Erdafitinib
Eribulin
Erlotinib
Estramustine
Etoposide
Etoposide phosphate
Everolimus
Exemestane
Floxuridine
Fludarabine
Flutamide
Fulvestrant
Futibatinib
Gefitinib
Gemcitabine
Gemtuzumab ozogamicin
Gilteritinib
Glasdegib
Glofitamab
Goserelin
Hydroxyurea
Ibritumomab
Ibrutinib
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imatinib
Infigratinib
Inotuzumab ozogamicin
Interferon
Ipilimumab
Irinotecan
Irinotecan liposome
Isatuximab
Ivosidenib
Ixabepilone
Ixazomib
Lapatinib
Larotrectinib
Lenalidomide
Lenvatinib
Letrozole
Leuprolide
Lisocabtagene maraleucel
Lomustine
Loncastuximab tesirine-lpyl
Lorlatinib
Lurbinectedin
Lutetium Lu 177 dotatate
Margetuximab-cmkb
Mechlorethamine
Megestrol acetate
Melphalan
Melphalan flufenamide
Mercaptopurine
Methotrexate
Midostaurin
Mirvetuximab soravtansine-gynx
Mitomycin-C
Mitotane
Mitoxantrone
Mobocertinib
Mogamulizumab-kpkc
Mosunetuzumab
Moxetumomab pasudotox
Nadofaragene firadenovec-vcng
Necitumumab
Nelarabine
Neratinib
Nilotinib
Nilutamide
Niraparib
Niraparib and Abiraterone
Nivolumab
Obinutuzumab
Ofatumumab
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Osimertinib
Oxaliplatin
Paclitaxel
Palbociclib
Panitumumab
Panobinostat
Pazopanib
Pegaspargase
Pembrolizumab
Pemetrexed
Pemigatinib
Pertuzumab
Pirtobrutinib
Polatuzumab vedotin
Pomalidomide
Ponatinib
Pralatrexate
Pralsetinib
Procarbazine
Quazartinib
Ramucirumab
Regorafenib
Relatlimab
Relugolix
Retifanlimab
Ribociclib
Ripretinib
Rituximab
Rituximab and human hyaluronidase
Rituximab-abbs
Rituximab-pvvr
Romidepsin
Rucaparib
Sacituzumab govitecan
Selinexor
Selpercatinib
Sipuleucel-T
Sonidegib
Sorafenib
Sotorasib
Streptozocin
Sunitinib
Tafasitamab-cxix
Tagraxofusp-erzs
Talazoparib
Talimogene Laherparepvec
Talquetamab
Tamoxifen
TAS-102
Tazemetostat
Tebentafusp-tebn
Teclistamab-cqyv
Temozolomide
Temsirolimus
Tepotinib
Thalidomide
Thioguanine
Thiotepa
Tisagenlecleucel
Tisotumab vedotin-tftv
Tivozanib
Topotecan
Toremifene
Tositumomab
Trabectedin
Trametinib
Trastuzumab
Trastuzumab deruxtecan
Trastuzumab-pkrb
Tremelimumab-actl
Tretinoin
Tucatinib
Umbralisib
Vandetanib
Vemurafenib
Venetoclax
Vinblastine
Vincristine
Vinorelbine
Vismodegib
Vorinostat
Zanubrutinib
Ziv-aflibercept
3. Guidelines for Chemotherapy and Dosing Modifications
3. Guidelines for Chemotherapy and Dosing Modifications
Box 3-1. Determination of Creatinine Clearance
Box 3-2. Determination of Target Area Under the Curve (AUC)
Box 3-3. Determination of Drug Dose
Box 3-4. Classification of Teratogenic Potential and Use in Pregnancy for Chemotherapy Agents
Table 3-1. Performance Scales
Table 3-2. Calculation of Body Surface Area in Adult Amputees
Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
4. Common Chemotherapy Regimens in Clinical Practice
4. Common Chemotherapy Regimens in Clinical Practice
Adrenocortical Cancer
Anal Cancer
Basal Cell Cancer
Biliary Tract Cancer
Bladder Cancer
Blastic Dendritic Cell Plasmacytoid Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Carcinoid Tumors and Neuroendocrine Tumors
Cervical Cancer
Colorectal Cancer
Endometrial Cancer
Esophageal Cancer
Gastric Cancer
Gastrointestinal Stromal Tumor (GIST)
Head and Neck Cancer
Hepatocellular Cancer
Kaposi's Sarcoma
Leukemia
Lung Cancer
Lymphoma
Malignant Melanoma
Malignant Mesothelioma
Merkel Cell Cancer
Multiple Myeloma
Myelodysplastic Syndrome
NTRK Gene Fusion Cancer
Osteogenic Sarcoma
Ovarian Cancer (Epithelial)
Ovarian Cancer (Germ Cell)
Pancreatic Cancer
Prostate Cancer
References
Renal Cell Cancer
Soft Tissue Sarcomas
Squamous Cell Cancer of the Skin
Testicular Cancer
Thymoma
Thyroid Cancer
Von Hippel-Landau Associated Cancers
Waldenström's Macroglobulinemia
5. Antiemetic Agents for the Treatment of Chemotherapy-Induced Nausea and Vomiting
5. Antiemetic Agents for the Treatment of Chemotherapy-Induced Nausea and Vomiting
Common Regimens for Chemotherapy-Induced Nausea and Vomiting
Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting:
Common Regimens for Radiation-Induced Nausea and Vomiting:
Front Matter
Preface
;